Ann: Phase I Clinical Trial Dosing Update No 3, page-42

  1. 917 Posts.
    lightbulb Created with Sketch. 437
    Well Benoodles, you keep saying that the AGN phase 2 result will "prove up" NYR on neuroprotection.

    Surely it must work both ways though. Nyrada's cardio protection must "prove up" that ARG-007 will also be protective of the heart.

    ARG-007 is probably 2-3 years ahead of NYR as well.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
30.0¢
Change
0.010(3.45%)
Mkt cap ! $62.37M
Open High Low Value Volume
29.0¢ 30.0¢ 28.0¢ $277.0K 957.1K

Buyers (Bids)

No. Vol. Price($)
2 31270 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 130414 1
View Market Depth
Last trade - 15.54pm 07/08/2025 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.